Clinical Trial Update: Single Dose, Weight-Based, Dose-Escalation Study With Intravenous ETI-204 in Adult Volunteers [Phase 1]

View source ↗

Summary

Phase 1, single-dose, weight-based dose-escalation intravenous study of ETI-204 in healthy adult volunteers has completed; the trial evaluated safety and pharma…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anthrax

Drugs mentioned

• ETI-204

Snippet

Sponsor: Elusys Therapeutics | Conditions: Anthrax | Phase 1 | Status: COMPLETED